APA aipamena

Cao, Y., Gao, A., Li, X., Min, H., He, C., Sun, X., . . . Zhou, J. (2021). Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation. Cancer Med.

Chicago Style aipamena

Cao, Yuandong, Aidi Gao, Xiaoqing Li, Han Min, Chao He, Xinchen Sun, Wei‐Qun Ding, and Jundong Zhou. "Elevated TAB182 Enhances the Radioresistance of Esophageal Squamous Cell Carcinoma Through G2‐M Checkpoint Modulation." Cancer Med 2021.

MLA aipamena

Cao, Yuandong, et al. "Elevated TAB182 Enhances the Radioresistance of Esophageal Squamous Cell Carcinoma Through G2‐M Checkpoint Modulation." Cancer Med 2021.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.